Summary
Background
Pulmonary embolism (PE) is a potentially life-threatening condition that mainly affects the people of advanced age. While certain blood group phenotypes (non‑O blood group) are known risk factors for the development of venous thromboembolism (VTE), there is no research which investigated the association of blood group genotypes with severity of PE. The aim of this study was to investigate the frequency of ABO blood group genotypes among the population of patients with PE and to investigate the correlation of the pulmonary embolism severity index (PESI) score to specific ABO blood group genotypes.
Material and methods
In this cross-sectional study 74 patients with PE diagnosed using CT pulmonary angiography were included and 303 blood donors without VTE or congenital thrombophilia participated as a control group. After isolation of genomic DNA ABO blood group genotype was determined using the polymerase chain reaction sequence-specific amplification (PCR-SSP) method.
Results
We observed a significantly higher frequency of A1B and BB genotypes in patients with PE compared to healthy individuals (A1B 14.9% vs. 4.3%, P < 0.001; BB 5.4% vs. 0.7%, P = 0.004), while the O1O1 genotype was significantly less frequent in patients (24.3% vs. 37.3%, P = 0.036). Analyzing the severity of the clinical presentation according to the PESI score, we did not find a correlation between the severity of the clinical presentation and a certain blood type genotype.
Conclusion
Patients with A1B and BB blood type genotype were at increased risk for developing pulmonary embolism, while patients with O1O1 genotype had a significantly lower risk of developing PE.
Similar content being viewed by others
References
ESC. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(543):603. https://doi.org/10.1093/eurheartj/ehz405.
Pun VC, Hart JE, Kabrhel C, Camargo CA Jr, Baccarelli AA, Laden F. Prospective study of ambient particulate matter exposure and risk of pulmonary embolism in the nurses’ health study cohort. Environ Health Perspect. 2015;123(12):1265–70. https://doi.org/10.1289/ehp.1408927.
Dentali F, Riva N, Turato S, et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013;11(12):2103–10. https://doi.org/10.1111/jth.12420.
Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–9. https://doi.org/10.1001/archinternmed.2010.199.
Erythropoulou-Kaltsidou A, Alkagiet S, Tziomalos K. New guidelines for the diagnosis and management of pulmonary embolism: Key changes. WJC. 2020;12(5):161–6. https://doi.org/10.4330/wjc.v12.i5.161.
Zhou XY, Ben SQ, Chen HL, Ni SS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res. 2012; https://doi.org/10.1186/1465-9921-13-111.
Wu O, Bayoumi N, Vickers MA, Clark PABO. (H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost. 2008;6(1):62–9. https://doi.org/10.1111/j.1538-7836.2007.02818.x.
Clark P, Wu O. ABO blood groups and thrombosis: a causal association, but is there value in screening? Future Cardiol. 2011;7(2):191–201. https://doi.org/10.2217/fca.10.191.
Franchini M, Capra F, Targher G, et al. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thrombosis J. 2007;5:14. https://doi.org/10.1186/1477-9560-5-14.
Wolpin BM, Kabrhel C, Varraso R, et al. Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost. 2010;104(5):962–71. https://doi.org/10.1160/TH10-05-0312.
Ward S, O’Sullivan J, O’Donnell JS. The relationship between ABO blood group, von Willebrand factor and primary hemostasis. Blood. 2020; https://doi.org/10.1182/blood.2020005843.
Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev. 2012;26(2):103–18. https://doi.org/10.1016/j.tmrv.2011.08.002.
Trégouët DA, Heath S, Saut N, et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood. 2009;113(21):5298–303. https://doi.org/10.1182/blood-2008-11-190389.
Kullab GJ, Zaidi ARZ, Albaqmi S, Alajlan H, Alsheef MA. ABO Blood Groups and the Risk of Venous Thromboembolism (VTE) Among Saudi Patients at a Tertiary Care Hospital in Riyadh. Blood. 2019;134(Supplement_1):4926. https://doi.org/10.1182/blood-2019-128050.
Jukić I, Bingulac-Popović J, Samaržija M, Lampalo M, Hećimović A, Đogić V, et al. Distribution of main alleles of the ABO system of blood groups in the Croatian population. Acta Medica Croat. 2017;71(4):235–40.
Song J, Chen F, Campos M, Bolgiano D, Houck K, Chambless LE, et al. Quantitative influence of ABO blood groups on factor VIII and its ratio to von Willebrand factor, novel observations from an ARIC study of 11,673 subjects. PLoS ONE. 2015;10(8):e132626. https://doi.org/10.1371/journal.pone.0132626.
Stowell SR, Stowell CP. Biologic roles of the ABH and Lewis histo-blood group antigens part II: thrombosis, cardiovascular disease and metabolism. Vox Sang. 2019;114(6):535–52. https://doi.org/10.1111/vox.12786.
Jukic I, Bingulac-Popovic J, Dogic V, et al. ABO blood groups and genetic risk factors for thrombosis in Croatian population. Croat Med J. 2009;50(6):550–8. https://doi.org/10.3325/cmj.2009.50.550.
Konstantinides SV, Torbicki A, Agnelli G, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69k. https://doi.org/10.1093/eurheartj/ehu283. [published correction appears in Eur Heart J. 2015 Oct 14;36(39):2642]..
Gassner C, Schmarda A, Nussbaumer W, Schönitzer D. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood. 1996;88(5):1852–6.
Anstee DJ. The relationship between blood groups and disease. Blood. 2010;115(23):4635–43. https://doi.org/10.1182/blood-2010-01-261859.
Hajizadeh R, Kavandi H, Nadiri M, Ghaffari S. Association of ABO blood group with incidence and outcome of acute pulmonary embolism. Turk Kardiyol Dern Ars. 2016;44(5):397–403. https://doi.org/10.5543/tkda.2016.43996.
Ewald DR, Sumner SC. Blood type biochemistry and human disease. Wiley Interdiscip Rev Syst Biol Med. 2016;8(6):517–35. https://doi.org/10.1002/wsbm.1355.
Murray GP, Post SR, Post GR. ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells. J Clin Pathol. 2020;73(6):347–9. https://doi.org/10.1136/jclinpath-2019-206182.
Franchini M, Makris M. Non‑O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus. 2013;11(2):164–5. https://doi.org/10.2450/2012.0087-12.
Dubinski D, Keil F, Won SY, et al. Pulmonary embolism in neurocritical care-introduction of a novel grading system for risk stratification: the Frankfurt AMBOS score. Neurosurg Rev. 2020; https://doi.org/10.1007/s10143-020-01310-6.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
T. Kereš, I. Jukić, T. Svaguša, I. Prkačin, J. Bingulac-Popović, M. Vinković, A. Hećimović, M. Živković and N. Parašilovac declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kereš, T., Jukić, I., Svaguša, T. et al. A1B and BB blood group genotypes are risk factors for pulmonary embolism. Wien Klin Wochenschr 133, 1179–1185 (2021). https://doi.org/10.1007/s00508-021-01882-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00508-021-01882-3